(Q37619497)

21 August 2017

1 reference

title

Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: opportunities and challenges (English)

1 reference

21 August 2017

cardiovascular disease

1 reference

Jennifer G Robinson

1

1 reference

21 August 2017

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

26

1 reference

21 August 2017

11

1 reference

21 August 2017

917-931

1 reference

https://scigraph.springernature.com/pub.10.2165/11318270-000000000-00000

21 August 2017

0 references

cites work

Hypercholesterolemia in elderly persons: resolving the treatment dilemma

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318270-000000000-00000

Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or=125 mg/dl treated with statins versus no lipid-lowering drug

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318270-000000000-00000

Does pravastatin promote cancer in elderly patients? A meta-analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318270-000000000-00000

An assessment of statin safety by muscle experts

21 January 2018

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program

1 reference

12 December 2020

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

1 reference

12 December 2020

Trends in aging--United States and worldwide.

1 reference

12 December 2020

Reconsidering medication appropriateness for patients late in life

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Epidemiology of dementia and Alzheimer's disease.

1 reference

12 December 2020

Gains in life expectancy after elimination of major causes of death: revised estimates taking into account the effect of competing causes

1 reference

12 December 2020

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

12 December 2020

Incidence and prevalence of dementia in the Cardiovascular Health Study

1 reference

12 December 2020

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial

1 reference

12 December 2020

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1 reference

12 December 2020

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

Statins and the risk of lung, breast, and colorectal cancer in the elderly

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

1 reference

12 December 2020

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

1 reference

12 December 2020

Risk factors for intracerebral hemorrhage in a pooled prospective study

1 reference

12 December 2020

Risks associated with statin therapy: a systematic overview of randomized clinical trials

1 reference

12 December 2020

Molecular and cellular basis of cardiovascular gender differences

1 reference

12 December 2020

Correlation of intracoronary ultrasound plaque characteristics in atherosclerotic coronary artery disease patients with clinical variables

1 reference

12 December 2020

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

12 December 2020

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Frailty, heart disease, and stroke: the Compression of Morbidity paradigm

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards

1 reference

12 December 2020

Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

1 reference

12 December 2020

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

1 reference

12 December 2020

The puzzle of predicting the impact of brain infarcts on cognitive impairment in the aging brain

1 reference

12 December 2020

Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection.

1 reference

12 December 2020

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

1 reference

12 December 2020

Dementia Screening in Primary Care

1 reference

12 December 2020

Statins, low-density lipoprotein cholesterol, and risk of cancer

1 reference

12 December 2020

Rethinking brain food

1 reference

12 December 2020

Systolic hypertension in older persons

1 reference

12 December 2020

An assessment of statin safety by hepatologists

1 reference

12 December 2020

Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction

1 reference

12 December 2020

Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk

1 reference

12 December 2020

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

12 December 2020

Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis

1 reference

12 December 2020

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

12 December 2020

Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study

1 reference

12 December 2020

Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study).

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Safety of aggressive lipid management

1 reference

12 December 2020

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study

1 reference

12 December 2020

A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)

1 reference

12 December 2020

Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease

1 reference

12 December 2020

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

12 December 2020

Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review

1 reference

12 December 2020

Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin.

1 reference

12 December 2020

Is it time for a cardiovascular primary prevention trial in the elderly?

1 reference

12 December 2020

Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).

1 reference

12 December 2020

Preventing chronic diseases: how many lives can we save?

1 reference

12 December 2020

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

12 December 2020

10.2165/11318270-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

19848438

Dimensions Publication ID

21 August 2017

0 references

1 reference

PubMed ID

19848438